The Enterprise Value as of September 2024 (TTM) for ReShape Lifesciences Inc. (RSLS) is 4.01M

According to ReShape Lifesciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.01M. This represents a change of 121.95% compared to the average of 1.80M of the last 4 quarters.

ReShape Lifesciences Inc. (RSLS) Historical Enterprise Value (quarterly & annually)

How has RSLS Enterprise Value performed in the past?

The mean historical Enterprise Value of ReShape Lifesciences Inc. over the last ten years is 11.06M. The current 4.01M Enterprise Value has changed 3.52% with respect to the historical average. Over the past ten years (40 quarters), RSLS's Enterprise Value was at its highest in in the December 2015 quarter at 15.98B. The Enterprise Value was at its lowest in in the June 2021 quarter at -13793250.00.

ReShape Lifesciences Inc. (RSLS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ReShape Lifesciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ReShape Lifesciences Inc. (RSLS) Average Enterprise Value

How has RSLS Enterprise Value performed in the past?

The current Enterprise Value of ReShape Lifesciences Inc. (RSLS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

ReShape Lifesciences Inc. (RSLS) Enterprise Value vs. Peers

How is RSLS’s Enterprise Value compared to its peers?

ReShape Lifesciences Inc.’s Enterprise Value is greater than Sintx Technologies, Inc. (2.48M), greater than Bone Biologics Corporation (874.47K), greater than Ra Medical Systems, Inc. (-1531031.00), greater than Tivic Health Systems, Inc. (-2054348.00), greater than Nuwellis, Inc. (2.21M), greater than Talis Biomedical Corporation (-37968206.00), greater than Tenon Medical, Inc. (2.63M), less than INVO Bioscience, Inc. (7.23M), greater than Helius Medical Technologies, Inc. (-3420946.00), greater than Heart Test Laboratories, Inc. (-3324807905.00), less than NeuroMetrix, Inc. (6.84M), less than Inspira Technologies Oxy B.H.N. Ltd. (19.67M), less than OpGen, Inc. (30.85M),

Build a custom stock screener for ReShape Lifesciences Inc. (RSLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ReShape Lifesciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ReShape Lifesciences Inc. (RSLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ReShape Lifesciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.